Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Samsung Electronics Co., Ltd.
  6. News
  7. Summary
    A005930   KR7005930003

SAMSUNG ELECTRONICS CO., LTD.

(A005930)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

S.Korea stocks end 1% higher on chip, biopharma boost, U.S. data in focus

11/15/2021 | 01:51am EST

* KOSPI rises, foreigners net buyers

* Korean won strengthens against U.S. dollar

* South Korea benchmark bond yield falls

* For the midday report, please click

SEOUL, Nov 15 (Reuters) - Round-up of South Korean financial markets:

** South Korea shares ended 1% higher on Monday, boosted by semiconductor and biopharmaceutical firms and as upbeat Chinese economic data lifted investor sentiment. The won inched up, while the benchmark bond yield fell.

** The benchmark KOSPI closed up 30.72 points, or 1.03%, at 2,999.52, after having gained 1.18% to its highest level since Nov. 4 earlier in the session.

** Among the heavyweights, South Korean chip giants Samsung Electronics and SK Hynix rose 1.13% and 4.23%, respectively, while Samsung Biologics and Celltrion surged 3.72% and 9.13% each.

** Shares of Celltrion jumped after the company's monoclonal antibody treatment received approval by the European Commission for COVID-19 treatment.

** Lifting the sentiment across the region was upbeat data from China, with annual growth in retail sales and industrial output both handily beating forecasts, despite fresh curbs to control COVID-19 outbreaks and supply shortages.

** Investors are now eyeing U.S. retail sales data due on Tuesday for any impact from the drop in consumer sentiment to a decade low reported for November, as people fretted over higher prices.

** Foreigners were net buyers of 396.1 billion won ($336.30 million) worth of shares on the main board.

** The won ended at 1,178.4 per dollar on the onshore settlement platform, 0.10% higher than its previous close.

** In offshore trading, the won was quoted at 1,177.9 per dollar, up 0.1% from the previous day, while in non-deliverable forward trading its one-month contract was quoted at 1,180.3.

** In money and debt markets, December futures on three-year treasury bonds rose 0.17 points to 108.65.

** The most liquid 3-year Korean treasury bond yield fell by 4.5 basis points to 1.924%, while the benchmark 10-year yield fell by 4.1 basis points to 2.301%. ($1 = 1,177.8200 won) (Reporting by Joori Roh; Editing by Shailesh Kuber)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
CELLTRION, INC. 2.37% 151000 End-of-day quote.-23.74%
LG CHEM, LTD. 4.75% 639000 End-of-day quote.3.90%
NAVER CORPORATION 2.31% 310000 End-of-day quote.-18.10%
SAMSUNG BIOLOGICS CO.,LTD. 3.79% 739000 End-of-day quote.-18.16%
SAMSUNG ELECTRONICS CO., LTD. 2.81% 73300 End-of-day quote.-6.39%
SK HYNIX INC. 6.17% 120500 End-of-day quote.-8.02%
All news about SAMSUNG ELECTRONICS CO., LTD.
01/28Health Care Up On Rotation Back Into '21 Leading Sectors -- Health Care Roundup
DJ
01/28WALL STREET STOCK EXCHANGE : US inflation figures and earnings reassure investors
01/28Samsung Electronics' Chip Sales in 2021 Surpass Those of Intel
MT
01/28Biogen to Sell Equity Stake in Samsung Bioepis JV to Samsung Biologics for Up to $2.3 B..
MT
01/28Nomura Adjusts Samsung Electronics' Price Target to 100,000 Won From 110,000 Won, Keeps..
MT
01/27S.Korea stocks set for worst week since onset of pandemic
RE
01/27Samsung SDI's Net Profit Surges 15% in Q4 FY21; Shares Decline 6%
MT
01/27Samsung Biologics to Buy Biogen's Stake in JV
DJ
01/27GLOBAL MARKETS LIVE : Tesla, Intel, UBS, The Gap, Netflix...
01/27MARKETSCREENER'S WORLD PRESS REVIEW : January 27, 2022
More news
Analyst Recommendations on SAMSUNG ELECTRONICS CO., LTD.
More recommendations
Financials
Sales 2021 278 689 B 230 B 230 B
Net income 2021 39 330 B 32,5 B 32,5 B
Net cash 2021 108 525 B 89,8 B 89,8 B
P/E ratio 2021 12,3x
Yield 2021 1,98%
Capitalization 492 142 B 407 B 407 B
EV / Sales 2021 1,38x
EV / Sales 2022 1,19x
Nbr of Employees -
Free-Float 82,7%
Chart SAMSUNG ELECTRONICS CO., LTD.
Duration : Period :
Samsung Electronics Co., Ltd. Technical Analysis Chart | A005930 | KR7005930003 | MarketScreener
Technical analysis trends SAMSUNG ELECTRONICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 39
Last Close Price 73 300,00 KRW
Average target price 101 307,69 KRW
Spread / Average Target 38,2%
EPS Revisions
Managers and Directors
Hyun-Suk Kim Co-President, Co-CEO & Director
Dongjin Koh Co-President, Co-CEO & Director
Kinam Kim President, Co-CEO & Director
Tae Moon Roh Co-President & Head-Research & Development
Hee-Chan Roh Chief Financial Officer
Sector and Competitors
1st jan.Capi. (M$)
SAMSUNG ELECTRONICS CO., LTD.-6.39%398 682
HTC CORPORATION-24.76%1 880
MERRY ELECTRONICS CO., LTD.-5.93%693
ZEPP HEALTH CORPORATION-2.77%309
JNTC CO., LTD.-10.96%305
UNIDEVICE AG-5.78%27